Abstract:Abstract Background: Folate deficiency is classically taught as a cause of anemia; with the advent of widespread dietary fortification, the prevalence of folate deficiency in the general population has decreased significantly. Recent studies have examined the yield of testing for folate deficiency and questioned its value, demonstrating negligible clinical yield across multiple care settings. However, patients with cancer are at increased high risk of folate deficiency. To our knowledge, no studies have specifically examined patterns and yield of folate testing among inpatients at a cancer institution. We sought to determine the yield of folate testing in this setting, and to characterize the patients found to have folate deficiency. Methods: We used our institutional clinical database to identify all inpatient folate and red blood cell folate (RBCF) tests done at our institution in calendar-year 2017. We included testing done in our Urgent Care Center in patients who were subsequently admitted to the hospital. We defined folate deficiency as < 4.0 ng/mL according to our lab reference. Among patients with folate deficiency, we performed manual chart review to evaluate the presence of known risk factors for folate deficiency: alcohol abuse, gastrointestinal malabsorption, pancreatic insufficiency, culprit medications, end-stage renal disease requiring hemodialysis, malnutrition (defined as BMI <18.5), and hemolytic anemia. Results: A total of 1013 serum folate level tests were performed in 960 patients; one patient underwent RBCF testing alone. A majority of tests were done on medical rather than surgical patients (85% vs 13%). Overall, 69 (6.8%) of patients were found to have folate deficiency. Almost all patients with folate deficiency were anemic. Surprisingly, macrocytosis was infrequent in patients with folate deficiency in cancer; over 90% of patients had normal or even low MCV. Among 69 patients with folate deficiency, less than half the patients (N=28, 41%) had an identifiable risk factor for folate deficiency, most commonly medications. Identified malabsorption/ malnutrition, hemolysis, and hemodialysis collectively accounted for 7.2%, and no case was attributed to alcoholism. The degree of anemia was not significantly different between the patients with folate deficient and those with adequate folate levels. The mean MCV values were normal in both the folate deficient and folate replete patients. Co-testing of vitamin B12 levels was performed in 859 (85%) of testing instances; 23 (2.7%) had isolated B12 deficiency and 3 (0.3%) had concurrent folate and B12 deficiency. Conclusions: In our cohort of hospitalized cancer patients, folate testing identified deficiency in 6.8%, notably higher than in other studies of general populations. A higher rate of folate deficiency may have been present in this study due to the comorbidities associated with advanced malignancies and their treatments. Surprisingly, folate deficiency did not correlate with macrocytosis, which is characteristic of the folate deficiency-associated anemia in non-cancer patients. This may reflect more acute development of deficiency, or the presence of multiple factors affecting red cell production, thus "masking" the macrocytosis. Neither the degree of anemia nor the MCV provided guidance as to the presence of folate deficiency and a minority of deficient patients had identifiable risk factors. Folate deficiency, while not common in hospitalized cancer patients, needs to be considered in the presence of anemia, even in the absence of macrocytosis. Disclosures Soff: Amgen: Research Funding; Janssen: Research Funding.

Serum Folate Levels in Patients with Chronic Hemolytic Anemia on Regular Folic Acid Supplementation Before and After Dose Modification

Serum Homocysteine Levels and Their Relationship With Serum Vitamin B12, Folate, and Ferritin Levels in Transfusion-Dependent Thalassemic Children

Folate in the United States Population and Its Association with Congestive Heart Failure

Folic acid supplementation in children with sickle cell disease: study protocol for a double-blind randomized cross-over trial

Detectable Unmetabolized Folic Acid and Elevated Folate Concentrations in Folic Acid-Supplemented Canadian Children With Sickle Cell Disease

Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study

Effect of folic acid supplementation on plasma homocysteine in obese children: a randomized, double-blind, placebo-controlled trial

Serum Folate Concentrations in Exclusively Breastfed Preterm Infants Who Received No Supplementary Oral Folic Acid After Discharge: A Prospective Cohort Study

Serum Concentrations of Folate Forms Following Supplementation of Multimicronutrients with 400 µg or 800 µg Mix of (6S)-5-Methyltetrahydrofolate and Folic Acid (1:1) in Women of Childbearing Age

[Homocysteine, Folate Therapy and Outcome in Hemodialysis: Results from a Prospective Study].

High Serum Ferritin Levels among Blood Transfused Thalassemic Patients Admitted to the Department of Paediatrics in a Tertiary Care Centre: A Descriptive Cross-Sectional Study

Folate status response to chronic folic acid doses in large-scale population-based randomized intervention trial in young Chinese women

Low utility of serum folic acid blood tests in healthy children and adolescents, a nationwide cohort

Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells

Folate Testing and Deficiency in Hospitalized Cancer Patients

[Effect of Low-Dose Folate Treatment on Plasma Homocystyeine and Chemokine Levels in Patients with Hyperhomocysteinemia].

The Cerebrospinal Fluid Concentration of Methyltetrahydrofolate and Serum Folate in Children with Developmental Delay, Regression, and/or Refractory Epilepsy

A Daily Dose of 5 mg Folic Acid for 90 Days Is Associated with Increased Serum Unmetabolized Folic Acid and Reduced Natural Killer Cell Cytotoxicity in Healthy Brazilian Adults

Systematic Review and Bayesian Meta-analysis of the Dose-response Relationship between Folic Acid Intake and Changes in Blood Folate Concentrations

MTHFR Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment.

Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients